What Is Vyvanse Made Of? Ingredients Explained

Vyvanse contains one active ingredient: lisdexamfetamine dimesylate, a molecule in which the stimulant dextroamphetamine is chemically bonded to an amino acid called L-lysine. This bond makes the drug inactive until your body breaks it apart, which is the whole point of its design. The rest of the capsule or chewable tablet is filled with inactive ingredients that hold the formulation together, and those excipients can vary between brand-name and generic versions in ways that occasionally matter.

The Active Ingredient Is a Prodrug, Not a Stimulant

Lisdexamfetamine dimesylate is what pharmacologists call a prodrug. It does nothing on its own. The molecule is built by attaching dextroamphetamine (the active stimulant) to L-lysine (a naturally occurring amino acid your body already uses for protein synthesis) through a covalent chemical bond. Until that bond is broken, the drug is pharmacologically inert.¹ The “dimesylate” part of the full chemical name refers to the salt form used to stabilize the compound and improve its solubility, much like how many medications are formulated as hydrochloride or sulfate salts.

So when you swallow a Vyvanse capsule, you are not swallowing amphetamine. You are swallowing a locked version of amphetamine that requires biological machinery to unlock. That distinction drives nearly everything about how the drug behaves, from its gradual onset to its lower abuse potential compared to immediate-release stimulants.

How Your Body Unlocks the Drug

After you swallow Vyvanse, it dissolves and is absorbed from the gastrointestinal tract. The conversion to active dextroamphetamine happens primarily in the blood, specifically through contact with red blood cells.² Enzymes on or within red blood cells cleave the bond between L-lysine and dextroamphetamine, gradually freeing the active stimulant into your bloodstream.³

This enzymatic process is rate-limited, meaning your body can only convert so much lisdexamfetamine into dextroamphetamine per unit of time. You cannot speed it up by taking more. The result is a smoother ramp-up in blood levels compared to swallowing dextroamphetamine directly. Once freed, the dextroamphetamine works the same way it does in any other amphetamine medication: it promotes the release of dopamine and norepinephrine in the brain, particularly in circuits involved in attention and impulse control.⁴

What the Prodrug Design Does to the Drug’s Timing

Because the conversion happens gradually, Vyvanse reaches peak amphetamine levels in the blood later than an equivalent dose of immediate-release dextroamphetamine. In a head-to-head study in healthy volunteers, plasma amphetamine concentrations after Vyvanse took roughly an hour longer to begin rising and peaked about an hour later than after a matched dose of plain dextroamphetamine.⁵ At steady state with daily dosing, the active amphetamine hit its peak at a median of about three hours after the dose.⁶

The prodrug approach also makes blood levels more consistent from person to person. Compared to immediate-release dextroamphetamine at equivalent doses, Vyvanse produces a lower peak concentration with less variability between individuals and even between different doses in the same person.⁷ The total amount of dextroamphetamine your body ultimately gets exposed to is similar for equivalent doses, but the delivery curve is flatter and broader. This is why Vyvanse is labeled for once-daily dosing even though it is not a controlled-release formulation in the traditional sense. There are no beads, no wax matrices, no special coatings delaying dissolution. The slow delivery comes entirely from the chemistry of the molecule itself.

Inactive Ingredients in the Capsule and Chewable Tablet

Beyond the active lisdexamfetamine dimesylate, each Vyvanse formulation contains excipients: substances that give the pill its physical form and help it dissolve properly. The capsule formulation uses microcrystalline cellulose as a filler, croscarmellose sodium to help the contents break apart in your stomach, and magnesium stearate as a lubricant that prevents the powder from sticking to manufacturing equipment. The capsule shell itself is made of gelatin and contains colorants like titanium dioxide plus dyes that vary by dose strength, which is why different doses come in different-colored capsules.

The chewable tablet version uses a different set of excipients suited to a tablet you chew and swallow rather than a capsule you swallow whole. These include sweeteners and flavorings to make the tablet palatable, along with binders and disintegrants that differ from the capsule formula.

For most people, the inactive ingredients are irrelevant. They pass through your system or dissolve without any pharmacological effect. But they can matter if you have specific allergies or intolerances. People with a gelatin sensitivity, for instance, would need the chewable tablet rather than the capsule. And as discussed below, the excipients can differ between brand-name and generic versions, which occasionally creates real-world differences for some patients.

Why Vyvanse Can Be Taken With or Without Food

One practical advantage of the prodrug design is that Vyvanse’s absorption is remarkably insensitive to what is happening in your stomach. Because lisdexamfetamine is highly water-soluble and its conversion to dextroamphetamine happens in the blood rather than the gut, changes in gastric pH or transit time do not meaningfully alter how much active drug you end up with. A high-fat meal delays the peak by about an hour but does not change the total amount of dextroamphetamine your body absorbs.⁸ You can also open the capsule and dissolve the contents in water without affecting absorption, which is useful for people who have trouble swallowing pills.

This stability extends even to people who have had gastric bypass surgery. A study comparing patients who had undergone Roux-en-Y gastric bypass with non-surgical controls found equivalent blood levels of both intact lisdexamfetamine and the released dextroamphetamine across all measured parameters.⁹ That is unusual. Many medications become unpredictable after bariatric surgery because they rely on a specific gut environment for absorption. Vyvanse sidesteps that problem because its critical conversion step happens after absorption, not during it.

The Chemistry Behind Abuse Deterrence

The prodrug design was not created solely for smooth drug delivery. A major motivation was reducing the potential for misuse. Stimulant medications carry a risk of abuse, particularly when people crush and snort pills or dissolve and inject them to get a rapid, intense high. These routes of administration work because they bypass the slow absorption of the gut and deliver a large dose of active drug to the brain quickly.

With Vyvanse, crushing or injecting the powder would deliver lisdexamfetamine, not dextroamphetamine. Since the inactive prodrug still needs red blood cell enzymes to convert it, snorting or injecting it cannot produce the sudden spike in brain amphetamine levels that makes those routes attractive to people seeking a euphoric rush.¹⁰ The conversion is still rate-limited regardless of how the prodrug enters the body. This does not make abuse impossible, but it removes the pharmacokinetic reward that drives most stimulant misuse patterns.

It is worth being honest about the limits of this design. Someone who takes very large oral doses of Vyvanse will still eventually generate high dextroamphetamine levels, just more slowly. The prodrug creates a ceiling on how fast the drug can hit, not on how much total stimulant a person can accumulate over hours. The abuse deterrence is real but not absolute.

Brand-Name Versus Generic Formulations

Vyvanse’s patent exclusivity expired and generic versions of lisdexamfetamine dimesylate became available in the United States in 2023. Generic medications must meet FDA bioequivalence standards: the generic’s blood levels of the active drug need to fall within a defined window of the brand-name product’s levels, typically staying between 80% and 125% of the reference product’s key measurements.¹¹

The active ingredient is the same across brand and generic products. Where they can differ is in the inactive ingredients: fillers, binders, disintegrants, and colorants. These differences are not supposed to affect how the drug performs, but case reports have documented patients who experienced changes in symptom control or side effects after switching from brand-name Vyvanse to a generic. The suspected culprit in these cases is not the lisdexamfetamine itself but rather the excipients altering the release or dissolution profile in subtle ways.¹¹ Whether this is a widespread problem or a rare sensitivity issue remains unclear, but it is something to be aware of if you switch and notice a change.

How Your Body Eliminates Vyvanse

Once the dextroamphetamine is freed from its lysine partner, it follows the same metabolic fate as dextroamphetamine from any source. The kidneys do most of the work. In a study tracking radiolabeled lisdexamfetamine, about 42% of the administered dose was recovered in urine as dextroamphetamine, roughly 25% appeared as hippuric acid (a benign metabolic byproduct), and only about 2% came out as the intact, unconverted prodrug.¹² Almost nothing left the body through the feces. The L-lysine that gets cleaved off simply enters your body’s normal amino acid pool and gets used or recycled like any other lysine molecule.

The fact that the vast majority of the prodrug gets converted means the design is efficient. You are not wasting most of the dose on an unconvertible fraction. And the presence of hippuric acid as a major urinary metabolite is a normal finding; hippuric acid is produced from benzoic acid metabolism and shows up in urine from many dietary sources as well.

Urinary pH and How Long the Drug Lingers

One factor that influences how quickly dextroamphetamine clears your system is the pH of your urine. Amphetamines are weak bases, and in acidic urine they become ionized, which prevents them from being reabsorbed by the kidneys. In alkaline urine, more of the drug stays un-ionized and gets reabsorbed back into the bloodstream, extending its duration of action. This is basic pharmacology that applies to all amphetamine formulations, not just Vyvanse.

In practice, this means that substances or diets that make urine more alkaline, such as sodium bicarbonate or heavily plant-based diets, can prolong exposure to dextroamphetamine released from Vyvanse.¹³ Conversely, acidic urine speeds elimination. A study measuring amphetamine concentrations in urine after therapeutic doses found that urine pH had a statistically meaningful effect on how much amphetamine showed up, with the effect size of pH being about a third as large as the effect of time since dosing.¹⁴ This is not a trivial influence. If you are taking Vyvanse and notice the medication seems to wear off unusually quickly or linger longer than expected on different days, what you ate or drank that day and how it affected your urine pH could be part of the explanation.

This pH sensitivity is also relevant for drug testing. The amount of amphetamine detected in a urine sample depends not only on when you took the medication but on how acidic or alkaline the sample is. Clinicians and testing labs are generally aware of this variable, but patients sometimes are not.

Chemical Stability and Storage

Lisdexamfetamine dimesylate is a relatively stable compound under normal storage conditions. Forced degradation studies, in which researchers deliberately expose the molecule to harsh conditions, have shown that it holds up well under mild acid and mild alkaline environments. Meaningful breakdown only begins under conditions far more extreme than anything found in the human body or a medicine cabinet, requiring strong acid or base concentrations sustained over hours.¹⁵ This stability is consistent with the drug’s behavior in the GI tract: your stomach acid does not prematurely cleave the prodrug bond. The conversion depends on specific enzymatic activity, not chemical conditions.

For everyday storage, Vyvanse capsules and chewable tablets are kept at room temperature, away from moisture and light, following standard pharmaceutical handling. There is no special refrigeration requirement, and the medication does not degrade in any unusual way if briefly exposed to heat, though prolonged extreme temperatures should be avoided as with any medication.

What the Dissolved-in-Water Option Actually Means

The prescribing information for Vyvanse notes that you can open the capsule and dissolve the contents in water, orange juice, or yogurt. This is sometimes misunderstood as an alternative formulation or a trick for dose adjustment. In reality, it reflects the drug’s high water solubility and the fact that its conversion does not depend on the capsule shell or any mechanical release mechanism. Whether the powder hits your stomach inside a gelatin capsule or pre-dissolved in a glass of water, the same amount of lisdexamfetamine gets absorbed and the same rate-limited enzymatic conversion follows.⁸

Some patients and parents of children prescribed Vyvanse use this property to titrate doses more finely by dissolving a capsule in a measured volume of water and drinking a fraction. While this is sometimes discussed in clinical practice, it is an off-label use, and the consistency of the solution over time has not been formally studied in the same way the intact capsule has. If you are considering this approach, it is a conversation to have with your prescriber rather than something to improvise at home.